EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Extensive Deep Vein Thrombosis in a Young Man Taking Tirzepatide for Weight Loss

Mohammed Fareeduddin Farooqi, Muhammad Arshad Mehmood, Maria Khan, Hafiz Muhammad Salman, Adnan Agha

AACE Clinical Case Reports · 2024-11 · 10 (6) · 261-263

DOI: 10.1016/j.aace.2024.08.011 ↗

Kurz gefasst

Fallbericht in der Zeitschrift AACE Clinical Case Reports, 2024-11. Verfasst von Mohammed Fareeduddin Farooqi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Tawam Hospital, Al Ain, United Arab Emirates. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Obesity and rapid weight loss are risk factors for developing deep vein thromboses (DVTs). Our aims were to present a patient who developed extensive DVT after relatively rapid and severe weight loss that followed taking tirzepatide and to raise the awareness among health care professionals regarding the risk of DVT that can be associated with significant weight loss due to these agents. Case Report: We present the case of a 20-year-old young man, with raised body mass index of >35 kg/m2, who was initiated on tirzepatide treatment for weight loss, with 12-kg weight lost over 6 weeks. The patient did not have any risk factors for thrombophilia including family history, any recent travel, immobilization, recent infections, or recent surgeries. He presented with left leg swelling, and physical examination revealed signs of proximal DVT, and ultrasound Doppler and computed tomography venography confirmed extensive left-sided DVT with complete obstruction of the common femoral and iliac veins. He underwent mechanical thrombectomy and was maintained on anticoagulation therapy. His investigations for thrombophilia screening excluded any other cause for DVT, with the etiology attributed to possibly rapid weight loss.

Discussion

Newer and potent glucagon-like peptide 1 receptor agonists like tirzepatide are commonly used nowadays to induce weight loss in obese patients.

Conclusion

Adequate risk assessments and close monitoring should be performed in patients initiating glucagon-like peptide 1 receptor agonists, particularly if they have risk factors for developing venous thromboembolism.

Schlagwörter

Stichwörter der Autor:innen

deep vein thrombosisglucagon-like peptide-1 receptor agonisttirzepatide

Autor:innen und Institutionen

  • Department of Internal Medicine, Tawam Hospital, Al Ain, United Arab Emirates.
  • Pharmacy Department, Tawam Hospital, Al Ain, United Arab Emirates.
  • Department of Internal Medicine, College of Medicine & Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Zitieren

APA

Farooqi, M. F., Mehmood, M. A., Khan, M., Salman, H. M., & Agha, A. (2024). Extensive Deep Vein Thrombosis in a Young Man Taking Tirzepatide for Weight Loss. AACE Clinical Case Reports, 10(6), 261-263. https://doi.org/10.1016/j.aace.2024.08.011

Vancouver

Farooqi MF, Mehmood MA, Khan M, Salman HM, Agha A. Extensive Deep Vein Thrombosis in a Young Man Taking Tirzepatide for Weight Loss. AACE Clinical Case Reports. 2024;10(6):261-263. doi:10.1016/j.aace.2024.08.011

BibTeX
@article{Farooqi2024,
  author = {Farooqi, Mohammed Fareeduddin and Mehmood, Muhammad Arshad and Khan, Maria and Salman, Hafiz Muhammad and Agha, Adnan},
  title = {Extensive Deep Vein Thrombosis in a Young Man Taking Tirzepatide for Weight Loss},
  journal = {AACE Clinical Case Reports},
  year = {2024},
  volume = {10},
  number = {6},
  pages = {261--263},
  doi = {10.1016/j.aace.2024.08.011}
}
Kostenlos starten →